Evidence mapPaperPMID 41767747Full record

ReviewJournal of pharmaceutical analysis2026

Latest surface plasmon resonance advances for G protein-coupled receptors.

Giulia De Soricellis, Enrica Calleri, Sofia Salerno, Gloria Brusotti, Sara Tengattini, Caterina Temporini, Gabriella Massolini, Francesca Rinaldi

Abstract readReview
In one paragraph

Review in Journal of pharmaceutical analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giulia De SoricellisDepartment of Drug Sciences, University of Pavia, Pavia, 27100, Italy.
Enrica CalleriDepartment of Drug Sciences, University of Pavia, Pavia, 27100, Italy.
Sofia SalernoDepartment of Drug Sciences, University of Pavia, Pavia, 27100, Italy.
Gloria BrusottiDepartment of Drug Sciences, University of Pavia, Pavia, 27100, Italy.
Sara TengattiniDepartment of Drug Sciences, University of Pavia, Pavia, 27100, Italy.
Caterina TemporiniDepartment of Drug Sciences, University of Pavia, Pavia, 27100, Italy.
Gabriella MassoliniDepartment of Drug Sciences, University of Pavia, Pavia, 27100, Italy.
Francesca RinaldiDepartment of Drug Sciences, University of Pavia, Pavia, 27100, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) are a big family of membrane proteins which represent one of the main classes of drug targets. However, their investigation presents several challenges, among which their instability outside the membrane environment. Different strategies for the drug discovery of this target are available, and surface plasmon resonance (SPR) stands out as one of the most informative and widespread binding assays, with many advantages such as real-time and label-free analyses resulting in the definition of both affinity and kinetic constants. This review covers the applications of SPR in GPCR drug discovery of the last 10 years and classifies the papers based on the immobilization strategy on the SPR sensor chip to maintain receptor stability. In particular, GPCR immobilization can occur in its native membrane by immobilizing whole cells or membrane fragments, using membrane mimetics (such as lipoparticles, lentiviral particles, liposomes, lipoproteins, nanodiscs, or planar lipid membranes) or immobilizing the isolated receptor stabilized by the use of detergents or engineering approaches. Different examples were considered and pros and cons of each strategy were presented.

Indexed as

Drug discoveryG protein-coupled receptorsMembrane proteinsScreeningSurface plasmon resonance

Identifiers

PMID41767747
PMCPMC12936522

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.